Monthly Archives: July 2022

hello wordl 7-21-22 (contains spoilers)

Leave a reply

It’s been three or five these days. Today it was five.

(7 means not solved successfully)
(7 means not solved successfully)

https://hellowordl.net/

Day 17 of the EVFM Short Squeeze (post-close post) Who is Todd Stewart Cox?

Leave a reply

Disclaimer: None of this is investment advice. The logic here may be bad and should not be relied upon. My assumptions may be bad and should not be relied upon. This post reflects my opinion. I may hold positions in securities I write about, and I believe in what I write.

First off, today’s trading was whaaaaaattttttt. Low volume and big drops. We haven’t restarted the 10 day streak, but after close, the stock price drifted back up to about 88c in normally meaningless after hours trading.

I have the same feeling from my prior post: This makes absolutely no sense to me. Really, zero sense.

As I’ve posted over and over, I believe this stock is worth $1+ or $0. Nothing in between.

And then today’s news that a guy named Todd Stewart Cox is now the holder (along with his wife Kathy Overstreet Cox) of 3,919,866 shares of EVFM.

But who is Todd Stewart Cox?

I did a cursory search to see if there’s any hedge fund manager by that name in Texas. No dice.

I did a search of all text on EDGAR since 2001 for different permutations of TODD STEWART COX. The only time this guy shows up is from today’s filings.

The best I could come up with is that he’s an elder in his church and is involved with Sacred Selections adoption agency(?) that promotes adoption as an alternative to abortion.

Is he pro-contraceptives? Is that why he’s taken a 9.29% chunk of Evofem? Does Evofem’s tech qualify to Todd Cox as something worth promoting? Is he just a businessman who identifies Evofem as the next big thing and feels like he might as well make even more money?

I do not have answers.

My hope is that he’s just a dude who is in favor of what Evofem is doing. I can’t imagine that he bought millions of shares just to watch the company go belly-up.

I just find it bizarre that a virtually unknown would take such a large stake.

Meanwhile, today I averaged down from 90c/share to 89c/share.

Day 15 of the EVFM Short Squeeze (post-close post) Jeffrey Hung Morgan Stanley Opinion

1 Reply

Disclaimer: None of this is investment advice. The logic here may be bad and should not be relied upon. My assumptions may be bad and should not be relied upon. This post reflects my opinion. I may hold positions in securities I write about, and I believe in what I write.

I saw an update today on Fidelity’s ATP that purports to be from a Morgan Stanley analyst: “Morgan Stanley Maintains Underweight on Evofem Biosciences, Lowers Price Target to $0.75.”

This makes absolutely no sense to me. Really, zero sense.

As I’ve posted over and over, I believe this stock is worth $1+ or $0. Nothing in between. I would expect a Morgan Stanley analyst to do at least some cursory research before forming an opinion. I don’t know how anyone who is aware that delisting in the case of Evofem may bankrupt the company and who most certainly would know that maintaining a price below $1 would ultimately get the company delisted would provide a price target of less than a dollar.

My opinion is that either Jeff Hung, Morgan Stanley research analyst and graduate of MIT, Yale, and Johns Hopkins, doesn’t know how to read filings and then have thoughts or that it’s not a real Jeff Hung of Morgan Stanley release.

If this isn’t real, it reeks of illegal short-and-distort as part of greater stock price manipulation. If it is real, stock analyst sounds like the easiest job in the world. And one Jeff Hung certainly didn’t need a degree in nuclear engineering to do.

Evofem was two days away from reestablishing compliance with the Nasdaq’s price requirement, as yesterday was Day 8 of the 10 consecutive needed. Now the day count resets. Disappointing, sure, but it starts over on Monday and with more people aware of this company. I like the odds that Evofem survives.